Effectiveness of uterine fibroids treatment assessed in Norway in December 2019

28

Jan 2020

In December 2019, the Norwegian Institute of Public Health (NIPH) released a health technology assessment report regarding the effectiveness of uterine fibroids treatment. This assessment was initially commissioned to NIPH by the Centre for joint decision-making (Samvalgssenteret), which provides patients with relevant and reliable information about a diagnosis and available treatment options. The main objective of the report was to summarize key findings from systematic reviews about the comparative effectiveness of relevant treatment options for women with fibroids in the uterus. The appropriate treatment options are pharmacological treatment, embolization, myomectomy, and hysterectomy. The treatment options had to be compared to each other or no treatment (placebo).

The following results were obtained by NIPH:

  • Hysteroscopic myomectomy probably increases the chance of getting pregnant compared to the absence of the treatment, but this result is uncertain due to wide confidence intervals
  • Tranexamacid probably reduces bleeding in comparison to placebo
  • Embolization probably reduces the time that is needed to get back to the activity in comparison to myomectomy and hysterectomy
  • Selective progesterone receptor modulators possibly reduce symptoms in comparison to placebo
  • Non-steroidal anti-inflammatory drugs probably reduce bleeding in comparison to placebo
  • No evidence for the determination of the effectiveness of danazol or progestogens is available.

See the full health technology assessment report in Norwegian here.

On our website, you can order a ready-made report on reimbursement situation for hysterectomy in benign and malignant diseases of uterus. The report includes the reimbursement situation of:

  • subtotal hysterectomy;
  • total hysterectomy;
  • radical hysterectomy.

Click here to see details.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Nov 2022

In November 2022, NHS Digital published a final summary of core changes from OPCS-4.9 to OPCS-4.10 to be introduced from April 01, 2023. OPCS-4 is a statistical classification for clinical coding of interventions and procedures undertaken within the NHS. It is updated every three years. A total of 236 new four-character codes will be implemented in OPCS-4.10. Key changes concern cardiovascular, gastrointestinal, endoscopy, ENT, nephrology and urology, neurology and neurosurgery, obstetrics and gynecology, orthopedic, and breast surgery fields.

Read more

23

Nov 2022

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 21738 of November 4, 2022, Tuscany Regional Healthcare has published assessments of three medical devices in the orthopedics, surgical procedures, and peripheral vascular areas.

Read more

11

Nov 2022

MedTech-related health technology assessments from NIHR in October 2022
In October 2022, the National Institute for Health and Care Research (NIHR) in England released one MedTech-related report in its Health Technology Assessment (HTA) Journal, which concerned photodynamic versus white-light-guided resection of non-muscle-invasive bladder cancer. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

09

Nov 2022

On October 31, 2022, the Dental and Pharmaceutical Benefits Agency (TLV) initiated conducting a theme survey for technologies used for the diagnosis or treatment of lung or colorectal cancer. Manufacturers of medical devices have an opportunity to notify TLV about a new product related to the theme of the survey. The notification form is available on the TLV website and should be submitted no later than November 22, 2022.

Read more

08

Nov 2022

In October 2022, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (YAG laser vitreolysis for symptomatic vitreous floaters, transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine), one Medical Technologies Guidance (Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer) and three new Medtech Innovation Briefings (O2matic PRO 100, Daylight, Signatera). Also, one new clinical guideline was published on osteoarthritis.

Read more